Kellogg Iparraguire Monzon is categorized under Internal Medicine Doctors in Miami, FL and active since 2010.
Kellogg Iparraguire Monzon was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact E Kellogg Iparrag at the company’s single location by writing to 8950 North Kendall Drive # 302, Miami, Florida FL 33176 or by phoning (305) 595-4070. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Kellogg Iparraguire Monzon |
Contact Person: | E Kellogg Iparrag |
Address: | 8950 North Kendall Drive # 302, Miami, Florida 33176 |
Phone Number: | (305) 595-4070 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Kellogg Iparraguire Monzon was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact E Kellogg Iparrag for inquiries that concern Kellogg Iparraguire Monzon by calling the company number (305) 595-4070, as your correspondence is most welcome. Additionally, the physical location of the single location of Kellogg Iparraguire Monzon can be found at the coordinates 25.68768,-80.34061 as well as the street address 8950 North Kendall Drive # 302 in Miami, Florida 33176.
For its online presence, you may visit Kellogg Iparraguire Monzon’s website at and engage with its social media outlets through on Twitter and on Facebook.